Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
737.5 GBX | +0.20% | +1.80% | -6.71% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Apr. 18 | DiscoverIE set to meet full-year expectations; maintains momentum | AN |
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.81 times its estimated earnings per share for the ongoing year.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Electronic Equipment & Parts
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.71% | 896M | B- | ||
+33.07% | 79.23B | B+ | ||
+62.68% | 73.18B | B- | ||
-3.96% | 34.75B | A- | ||
-8.16% | 31.45B | A+ | ||
-9.72% | 13.87B | B+ | ||
-4.82% | 10.89B | B+ | ||
+11.74% | 10.09B | C- | ||
-6.15% | 9.76B | C | ||
+33.54% | 8.86B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DSCV Stock
- Ratings discoverIE Group plc